好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2008 Annual Meeting | Genetics of Epilepsy

Wednesday 04/16/08
02:00 PM - 06:00 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Integrated Neuroscience
History of Neurology, Epilepsy, Neurogenetics and Gene Therapy
No CME available
Event Timeline
02:00 PM - 03:00 PM Break
02:00 PM - 06:00 PM Abstract 001 - Serotonin Transporter Gene Variation and Prediction of Pharmacoresistance in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis
02:00 PM - 06:00 PM Abstract 001 - Hippocrates [amp] [italic]The Sacred Disease[/italic]: Who Won [ndash] God or Neuroscience?
02:00 PM - 06:00 PM Abstract 002 - Significant Association between Polymorphisms in a Drug-Transporter Gene (ATP-Binding Cassette Family [ndash] [italic]ABCC2[/italic]) and Pharmacoresistance to Antiepileptic Drug Therapy in Mesial Temporal Lobe Epilepsy
02:00 PM - 06:00 PM Abstract 002 - Familial Cortical Myoclonic Tremor with Epilepsy: Clinical Characteristics and Exclusion of Linkage to 8q and 2p in a Large French Family
02:00 PM - 06:00 PM Abstract 003 - A Novel Genetic Locus for Juvenile Myoclonic Epilepsy at Chromosome 5q33-q35
02:00 PM - 06:00 PM Abstract 003 - Frequency of Major Congenital Malformations and Dysmorphic Signs in the Offspring of Women with Epilepsy Followed Prospectively during Pregnancy
02:00 PM - 06:00 PM Abstract 004 - High-Order Gene-to-Gene Interactions in Antiepileptic Drug Resistance
02:00 PM - 06:00 PM Abstract 004 - Autosomal Recessive Idiopathic Generalized Epilepsies: Clinical and Genetic Study of 8 Tunisian Families
02:00 PM - 06:00 PM Abstract 005 - Overexpression of the C121W[beta]1 Mutation Results in a Differential Increase in Persistent Sodium Channel Activity in a Transgenic Model of Generalized Epilepsy with Febrile Seizures Plus (GEFS+)
02:00 PM - 06:00 PM Abstract 005 - New GLUT1 Mutation in a Child with Treatment-Resistant Epilepsy
02:00 PM - 06:00 PM Abstract 006 - The Epilepsy Genetic Association Database (epiGAD)
02:00 PM - 06:00 PM Abstract 006 - A Mutation of the Voltage-Gated Sodium Channel [beta]1 Subunit Causes Severe Myoclonic Epilepsy of Infancy through a Mechanism Involving Loss of Expression
02:00 PM - 06:00 PM Abstract 007 - Relationship between Valproate Plasma, CSF and Brain Pharmacokinetics and Anti-Seizure Pharmacodynamics: Evidence Against a Direct Receptor Effect?
02:00 PM - 06:00 PM Abstract 008 - Expression of [italic]PTPRM[/italic] Gene Is Increased in Surgical Specimens of Patients with Medically Refractory Mesial Temporal Lobe Epilepsy with Hippocampal Atrophy
Faculty Disclosures
Massimo Pandolfo, MD, FAAN Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to AAN interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with AAN that is relevant to AAN interests or activities.
Eva Andermann, MD, PhD No disclosure on file
Eloi Magnin No disclosure on file
Damian Consalvo, MD No disclosure on file
Nigel C. Tan, MBBS No disclosure on file
Man Seok Park, MD, PhD No disclosure on file
No disclosure on file
Iscia Lopes-Cendes, MD, PhD No disclosure on file
Ki H. Cho, MD, PhD No disclosure on file
Mariana S. Silva No disclosure on file
Colin H. Chalk, MD Dr. Chalk has nothing to disclose.
Florencia Aguirre No disclosure on file
Myeong-Kyu Kim No disclosure on file
Seung-Han Lee, MD, PhD Dr. Lee has nothing to disclose.
Fernando Cendes, MD, PhD, FAAN Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Elizabeth Bilevicius, MD No disclosure on file
Carlos A. Guerreiro, MD, FAAN No disclosure on file
Pierre Labauge, MD Dr. Labauge has nothing to disclose.
Lucien Rumbach, MD No disclosure on file
Marcelo A. Kauffman, MD No disclosure on file
Todd Arthur, MD No disclosure on file
Marie Vidailhet, MD, PhD No disclosure on file
Laurel Slaughter, MD No disclosure on file
Ulf Kallweit No disclosure on file
Imen Kacem, MD Dr. Kacem has nothing to disclose.
Gustavo A. Patino, MD, PhD Dr. Patino has received publishing royalties from a publication relating to health care. Dr. Patino has received personal compensation in the range of $0-$499 for serving as a project mentor with Manning Publications.
Claudia V. Maurer-Morelli, PhD No disclosure on file
Joachim M. Baehring, MD, FAAN Dr. Baehring has nothing to disclose.
Samuel F. Berkovic, MD, FRACP No disclosure on file
Neetha Shetty-Alva, MD No disclosure on file
Silvia Kochen No disclosure on file
Ronald C. Reed, PharmD No disclosure on file
Robert E. Hogan, MD Dr. Hogan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. The institution of Dr. Hogan has received research support from Biogen Inc. The institution of Dr. Hogan has received research support from Engage Therapeutics. The institution of Dr. Hogan has received research support from Otsuka Pharmaceuticals. The institution of Dr. Hogan has received research support from Cerevel Therapeutics.
Yosr Hizem No disclosure on file
Ashish V. Kapoor, MD, FAAN Dr. Kapoor has nothing to disclose.
Newton Agrawal, MD, PhD No disclosure on file
R. Ratnapriya No disclosure on file
Klaus Gehring, MD No disclosure on file
Jens Wuerfel, MD Dr. Wuerfel has received personal compensation for serving as an employee of MIAC AG. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Actelion. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Wuerfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche.
Andreas Kowalik, MD No disclosure on file
Vicki L. Wheelock, MD Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for uniQure. Dr. Wheelock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for PRIME Continuing Medical 好色先生.
Samuel Lapalme-Remis, MD Dr. Lapalme-Remis has nothing to disclose.
Stephen Van Gaal, MD No disclosure on file
Momina Soudagar-Turkey, MD Dr. Soudagar-Turkey has nothing to disclose.